|
Of relevance to Resverlogix's planned Fabry Disease trial
|
3
|
Resverlogix Corp.
|
Aug 09, 2019 11:34AM
|
|
On or about September 30, 2019
|
6
|
Resverlogix Corp.
|
Sep 25, 2019 10:22AM
|
|
OncoFusion
|
3
|
Zenith Epigenetics
|
Jul 20, 2017 01:12PM
|
|
Oncology Discovery article on BET inhibitors
|
1
|
Zenith Epigenetics
|
Dec 10, 2015 04:10PM
|
|
One year after REDUCE-IT's 2018 AHA presentation
|
5
|
Resverlogix Corp.
|
Nov 11, 2019 07:34AM
|
|
Orphan Disease Announcement
|
2
|
Resverlogix Corp.
|
Sep 24, 2015 07:06AM
|
|
PACE CME Videos from ESC 2019
|
6
|
Resverlogix Corp.
|
Feb 11, 2020 10:42AM
|
|
PAH Trial now recruiting
|
9
|
Resverlogix Corp.
|
Sep 04, 2019 08:05PM
|
|
Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
4
|
Resverlogix Corp.
|
Nov 03, 2019 10:27PM
|
|
PCSK9 vaccination
|
5
|
Resverlogix Corp.
|
Jun 22, 2017 12:40PM
|
|
Pep Talk - Protein Science Week
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 14, 2019 11:31AM
|
|
Percent MACE reduction
|
2
|
Resverlogix Corp.
|
Dec 06, 2016 11:10AM
|
|
Perspective on # MACE events and timeline to top-line
|
9
|
Resverlogix Corp.
|
Sep 01, 2018 09:53AM
|
|
PFI-1 (aka PF-6405761)
|
5
|
Zenith Epigenetics
|
Jun 26, 2018 02:52PM
|
|
Pfizer to Acquire Medivation (Enzalutamide) for $14 B
|
5
|
Zenith Epigenetics
|
Aug 22, 2016 08:32AM
|
|
Phase 1 Renal Trial Completed
|
10
|
Resverlogix Corp.
|
Sep 20, 2016 06:45AM
|
|
Phase 1b/2 trial expected to initiate 1Q 2019
|
7
|
Zenith Epigenetics
|
Jan 04, 2019 10:51AM
|
|
Phase 1b/2 trial expected to initiate 1Q 2019
|
1
|
Zenith Epigenetics
|
Mar 06, 2019 10:45AM
|
|
Phase 2 Kidney Trial
|
7
|
Resverlogix Corp.
|
Jan 24, 2017 04:52PM
|
|
Please add US BIOAF listing to the Stock Quote Sidebar
|
1
|
BIOASIS TECHNOLOGIES INC
|
May 20, 2016 11:18AM
|
